SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Mendelian Randomisation study of the influence of eGFR on coronary heart disease.

Charoen, P; Nitsch, D; Engmann, J; Shah, T; White, J; Zabaneh, D; Jefferis, B; Wannamethee, G; Whincup, P; Mulick Cassidy, A; et al. Charoen, P; Nitsch, D; Engmann, J; Shah, T; White, J; Zabaneh, D; Jefferis, B; Wannamethee, G; Whincup, P; Mulick Cassidy, A; Gaunt, T; Day, I; McLachlan, S; Price, J; Kumari, M; Kivimaki, M; Brunner, E; Langenberg, C; Ben-Shlomo, Y; Hingorani, A; Whittaker, J; Pablo Casas, J; Dudbridge, F; UCLEB Consortium (2016) Mendelian Randomisation study of the influence of eGFR on coronary heart disease. Scientific Reports, 6. ISSN 2045-2322 https://doi.org/10.1038/srep28514
SGUL Authors: Whincup, Peter Hynes

[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (320kB) | Preview
[img]
Preview
HTML Published Version
Download (401kB) | Preview

Abstract

Impaired kidney function, as measured by reduced estimated glomerular filtration rate (eGFR), has been associated with increased risk of coronary heart disease (CHD) in observational studies, but it is unclear whether this association is causal or the result of confounding or reverse causation. In this study we applied Mendelian randomisation analysis using 17 genetic variants previously associated with eGFR to investigate the causal role of kidney function on CHD. We used 13,145 participants from the UCL-LSHTM-Edinburgh-Bristol (UCLEB) Consortium and 194,427 participants from the Coronary ARtery DIsease Genome-wide Replication and Meta-analysis plus Coronary Artery Disease (CARDIoGRAMplusC4D) consortium. We observed significant association of an unweighted gene score with CHD risk (odds ratio = 0.983 per additional eGFR-increasing allele, 95% CI = 0.970-0.996, p = 0.008). However, using weights calculated from UCLEB, the gene score was not associated with disease risk (p = 0.11). These conflicting results could be explained by a single SNP, rs653178, which was not associated with eGFR in the UCLEB sample, but has known pleiotropic effects that prevent us from drawing a causal conclusion. The observational association between low eGFR and increased CHD risk was not explained by potential confounders, and there was no evidence of reverse causation, therefore leaving the remaining unexplained association as an open question.

Item Type: Article
Additional Information: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Keywords: UCLEB Consortium
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: Scientific Reports
Article Number: 28514
ISSN: 2045-2322
Language: eng
Dates:
DateEvent
24 June 2016Published
6 June 2016Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 27338949
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/107956
Publisher's version: https://doi.org/10.1038/srep28514

Actions (login required)

Edit Item Edit Item